-
-
-
-
-
-
-
TG Therapeutics (TGTX) Misses Q1 EPS by 16c, raises guidance
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
-
-
-
-
-
-
TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Tops Q2 EPS by 9c
-
-
-
-
-
-
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
-
1,216,197 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

